First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: Jun 8, 2024

Meridian Bioscience Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Meridian Bioscience Inc
Accrued Liabilities Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Accrued Liabilities
$25.7m
CAGR 3-Years
30%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Accrued Liabilities
$144.7m
CAGR 3-Years
-4%
CAGR 5-Years
12%
CAGR 10-Years
11%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Accrued Liabilities
$590m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
6%
Align Technology Inc
NASDAQ:ALGN
Accrued Liabilities
$496.6m
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Accrued Liabilities
$146.2m
CAGR 3-Years
61%
CAGR 5-Years
43%
CAGR 10-Years
17%

See Also

What is Meridian Bioscience Inc's Accrued Liabilities?
Accrued Liabilities
25.7m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Accrued Liabilities amounts to 25.7m USD.

What is Meridian Bioscience Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
29%

Over the last year, the Accrued Liabilities growth was -17%. The average annual Accrued Liabilities growth rates for Meridian Bioscience Inc have been 30% over the past three years , 29% over the past five years .